Pregnant women still unaware of epilepsy drug risks: EMA hearing - Reuters

Reuters

Pregnant women still unaware of epilepsy drug risks: EMA hearing Reuters The headquarters of the European Medicines Agency (EMA), is seen in London, Britain, April 25, 2017. REUTERS/Hannah McKay. PARIS (Reuters) - More than three decades after links emerged between Sanofi's epilepsy drug valproate and birth defects, ... EMA Warns of Major Staff Losses in HQ RelocationRegulatory Focus EMA hearing over use of epilepsy drug for pregnant womenRTE.ie EMA Rings Alarm Bells Loudly on Brexit MoveApplied Clinical Trials Online (press release) (blog) EU News -Epilepsy Research UK -The Guardian -Financial Times all 17 news articles »

from Health - Google News http://ift.tt/2xDlACn